Oxaliplatin-induced haemolytic anaemia

Lancet

Volumn 354, Issue 9185, 1999, Pages 1179-1180

  Desrame, J ^a   Broustet, H ^b   Darodes De Tailly, P ^c   Girard, D ^d   Saissy, J M ^b  

^a Hop d'Instruction des Armees Begin   (France)

^b SERVICE D ENDOCRINOLOGIE   (France)

^c Ctr Transfus Sang Armees J J   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; OXALIPLATIN; PLATINUM COMPLEX;

AGED; ARTICLE; BACKACHE; BLOOD ANALYSIS; CASE REPORT; CHILL; COLORECTAL CARCINOMA; DRUG BLOOD LEVEL; DRUG INFUSION; FEMALE; FEVER; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; JAUNDICE; LIVER METASTASIS; PRIORITY JOURNAL; SCLERA DISEASE;

EID: 0033517549     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03827-1     Document Type: Article

References (5)

1. Extra J.M., Marty M., Brienza S., Misset J.L. Pharmacokinetics and safety profile of oxaliplatin. Semin Oncol. 25:1998;13-22.
2. Levi J.A., Aroney R.S., Dalley D.N. Haemolytic anaemia after cisplatin treatment. BMJ. 282:1981;2003-2004.
3. Marani T.M., Trich M.B., Armstrong K.S.et al. Carboplatin-induced immune hemolytic anemia. Transfusion. 36:1996;1016-1018.
4. Wrigh M.S. Drug-induced hemolytic anemias: increasing complications to therapeutic interventions. Clin Lab Sci. 12:1999;115-118.
5. Salama A., Göttsche B., Schleiffer T., Mueller-Eckhardt C. "Immune complex" mediated intravascular hemolysis due to IgM-cephalosporin-dependent antibody. Transfusion. 27:1987;460-463.